| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |